| Dr Peter Lee, MD | |
|
3100 Princeton Pike, Building 3, 3rd Floor, Lawrenceville, NJ 08648-2300 | |
| (609) 896-1793 | |
| (609) 896-1847 |
| Full Name | Dr Peter Lee |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 23 Years |
| Location | 3100 Princeton Pike, Lawrenceville, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225081334 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 25MA07810900 (New Jersey) | Secondary |
| 207R00000X | Internal Medicine | 25MA0781090 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Medical Center Of Princeton At Plainsboro | Plainsboro, NJ | Hospital |
| Capital Health Medical Center - Hopewell | Pennington, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Clinical Health Care Associates Of New Jersey Pc | 0749180198 | 664 |
| Princeton Healthcare Affiliated Physicians Pc | 2567598022 | 66 |
News Archive
Two leading insurers reported second-quarter earnings with rising profits this week.
Until now, brain scans obtained using fMRI – one of the most important imaging methods in use today – have been affected by fluctuations in the brain activity measured which could not be explained. Researchers at the Max Planck Institute for Human Cognitive and Brain Sciences in Leipzig and the Charité in Berlin have now shown that certain electric background rhythms in the brain, known as Alpha oscillations, alter the fMRI signal obtained with visual stimuli. To do this, they used a new approach in which quickly changing brain activity, which cannot be captured by the scanner, was measured using
CEL-SCI Corporation has announced that it is expanding the scope of its work towards creating a novel treatment and vaccination against the current H1N1 virus, as well as a future mutated form in which the virus has acquired greater morbidity and mortality.
Presidio Pharmaceuticals, Inc. announced today that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has authorized the initiation of a Phase 1 first-in-human clinical trial of PPI-461, an orally administered NS5A inhibitor for the treatment of hepatitis C virus (HCV). The Phase 1 clinical trial will be conducted in healthy volunteers.
Like jewels in a vault, our precious genetic material is stored in the nucleus of a cell-sequestered away from potentially damaging cellular components and toxins so that no harm can come to it. Yet over the course of a life moving through this world, our DNA does get damaged, and our cells have a host of complicated repair mechanisms to deal with such injuries.
› Verified 8 days ago
| Entity Name | Clinical Health Care Associates Of New Jersey Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447260435 PECOS PAC ID: 0749180198 Enrollment ID: O20040421001473 |
News Archive
Two leading insurers reported second-quarter earnings with rising profits this week.
Until now, brain scans obtained using fMRI – one of the most important imaging methods in use today – have been affected by fluctuations in the brain activity measured which could not be explained. Researchers at the Max Planck Institute for Human Cognitive and Brain Sciences in Leipzig and the Charité in Berlin have now shown that certain electric background rhythms in the brain, known as Alpha oscillations, alter the fMRI signal obtained with visual stimuli. To do this, they used a new approach in which quickly changing brain activity, which cannot be captured by the scanner, was measured using
CEL-SCI Corporation has announced that it is expanding the scope of its work towards creating a novel treatment and vaccination against the current H1N1 virus, as well as a future mutated form in which the virus has acquired greater morbidity and mortality.
Presidio Pharmaceuticals, Inc. announced today that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has authorized the initiation of a Phase 1 first-in-human clinical trial of PPI-461, an orally administered NS5A inhibitor for the treatment of hepatitis C virus (HCV). The Phase 1 clinical trial will be conducted in healthy volunteers.
Like jewels in a vault, our precious genetic material is stored in the nucleus of a cell-sequestered away from potentially damaging cellular components and toxins so that no harm can come to it. Yet over the course of a life moving through this world, our DNA does get damaged, and our cells have a host of complicated repair mechanisms to deal with such injuries.
› Verified 8 days ago
| Entity Name | Princeton Healthcare Affiliated Physicians Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518194323 PECOS PAC ID: 2567598022 Enrollment ID: O20100413000141 |
News Archive
Two leading insurers reported second-quarter earnings with rising profits this week.
Until now, brain scans obtained using fMRI – one of the most important imaging methods in use today – have been affected by fluctuations in the brain activity measured which could not be explained. Researchers at the Max Planck Institute for Human Cognitive and Brain Sciences in Leipzig and the Charité in Berlin have now shown that certain electric background rhythms in the brain, known as Alpha oscillations, alter the fMRI signal obtained with visual stimuli. To do this, they used a new approach in which quickly changing brain activity, which cannot be captured by the scanner, was measured using
CEL-SCI Corporation has announced that it is expanding the scope of its work towards creating a novel treatment and vaccination against the current H1N1 virus, as well as a future mutated form in which the virus has acquired greater morbidity and mortality.
Presidio Pharmaceuticals, Inc. announced today that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has authorized the initiation of a Phase 1 first-in-human clinical trial of PPI-461, an orally administered NS5A inhibitor for the treatment of hepatitis C virus (HCV). The Phase 1 clinical trial will be conducted in healthy volunteers.
Like jewels in a vault, our precious genetic material is stored in the nucleus of a cell-sequestered away from potentially damaging cellular components and toxins so that no harm can come to it. Yet over the course of a life moving through this world, our DNA does get damaged, and our cells have a host of complicated repair mechanisms to deal with such injuries.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Peter Lee, MD 3100 Princeton Pike, Building 3, 3rd Floor, Lawrenceville, NJ 08648-2300 Ph: (609) 896-1793 | Dr Peter Lee, MD 3100 Princeton Pike, Building 3, 3rd Floor, Lawrenceville, NJ 08648-2300 Ph: (609) 896-1793 |
News Archive
Two leading insurers reported second-quarter earnings with rising profits this week.
Until now, brain scans obtained using fMRI – one of the most important imaging methods in use today – have been affected by fluctuations in the brain activity measured which could not be explained. Researchers at the Max Planck Institute for Human Cognitive and Brain Sciences in Leipzig and the Charité in Berlin have now shown that certain electric background rhythms in the brain, known as Alpha oscillations, alter the fMRI signal obtained with visual stimuli. To do this, they used a new approach in which quickly changing brain activity, which cannot be captured by the scanner, was measured using
CEL-SCI Corporation has announced that it is expanding the scope of its work towards creating a novel treatment and vaccination against the current H1N1 virus, as well as a future mutated form in which the virus has acquired greater morbidity and mortality.
Presidio Pharmaceuticals, Inc. announced today that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has authorized the initiation of a Phase 1 first-in-human clinical trial of PPI-461, an orally administered NS5A inhibitor for the treatment of hepatitis C virus (HCV). The Phase 1 clinical trial will be conducted in healthy volunteers.
Like jewels in a vault, our precious genetic material is stored in the nucleus of a cell-sequestered away from potentially damaging cellular components and toxins so that no harm can come to it. Yet over the course of a life moving through this world, our DNA does get damaged, and our cells have a host of complicated repair mechanisms to deal with such injuries.
› Verified 8 days ago
Michael Roy Dash, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 123 Franklin Corner Rd, Suite 216, Lawrenceville, NJ 08648 Phone: 609-895-6800 Fax: 609-895-6988 | |
Dr. Neel Jitendra Gandhi, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2997 Princeton Pike, #201, Lawrenceville, NJ 08648 Phone: 609-771-0700 Fax: 609-771-8466 | |
Dr. Humaira Naseem Adenwalla, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3100 Princeton Pike Ste D, Lawrenceville, NJ 08648 Phone: 609-910-5556 | |
Dr. Sarah Anne Werbel, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3100 Princeton Pike, Bldg 4, Suite I, Lawrenceville, NJ 08648 Phone: 609-896-0303 Fax: 609-896-0308 | |
Dr. Robert Silverbrook, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3131 Princeton Pike, Suite204, Lawrenceville, NJ 08648 Phone: 609-306-8924 Fax: 215-364-3139 | |
Mrs. Daphne Duvalsaint Dadzie, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 168 Franklin Corner Rd, Building 1, Suite 2a, Lawrenceville, NJ 08648 Phone: 609-896-0075 Fax: 609-896-0079 | |
Dr. Jason Hollander, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 168 Franklin Corner Rd Bldg 1, Lawrenceville, NJ 08648 Phone: 609-924-4433 Fax: 609-924-4423 |